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Naive T cells undergo diff erentiation on signals received from the TCR and cytokine receptors and diff erentiate to specialized subsets characterized by their production of signature cytokines. Th17 cells produce IL-17 or IL-17A and IL-17F, which are major mediators of infl ammation and are critical for host defense against extracellular bacteria and fungi ( 1, 2 ) . IL-6, IL-21, and TGF-␤ 1 are critical factors that promote Th17 cell differentiation ( 1, 3 ) . Although IL-23 was originally thought to be important for inducing naive CD4 + T cells to become Th17 cells, naive CD4 + T cells do not express IL-23Rs ( 4 ) . Rather, IL-23 is now thought to aff ect the expansion, maintenance, and pathogenicity of Th17 cells ( 5 ) . IL-23 also induces IL-17 production from ␥ ␦ T cells and invariant NKT (iNKT) cells ( 6, 7 ) . Regardless of exactly how IL-23 works, current evidence clearly argues that IL-23 -mediated IL-17 production is crucial in host defense and in the pathogenesis of autoimmune diseases ( 8 -10 ) .
IL-6, IL-21, and IL-23 share the ability to activate Stat3, which was shown to be critical for Th17 cell diff erentiation in mouse and man ( 3, 11, 12 ) . Stat3 directly regulates the Il17 and Il21 genes but also regulates IL-23R expression ( 3, 12 ) . Furthermore, the aforementioned cytokines acting via Stat3 induce the retinoic acidrelated orphan receptor ␥ t (ROR ␥ t), the master regulator of Th17 cell diff erentiation ( 13 ) .
In contrast to T cells, much less is known about the ability of innate cell subpopulations to produce IL-17. We report that splenic lymphoid tissue inducer -like cells (LTi-like cells) constitutively express ROR ␥ t, IL-23R, CCR6, and aryl hydrocarbon receptor (AHR) ( 14 ) , and produce IL-17 and IL-22. Interestingly, with IL-23 had no eff ect on IL-17A production; however, IL-4 suppressed IL-23 -induced IL-17A production by WT and Rag2 Ϫ / Ϫ splenocytes ( Fig. S1 A, available at http://www .jem.org/cgi/content/full/jem.20072713/DC1). In addition to memory CD4 + T cells, iNKT cells are another important source of IL-17 ( 7 ) , but such cells are lacking in Rag2 Ϫ / Ϫ mice. Accordingly, anti-CD3/28 or ␣ -galactosylceramide ( ␣ -GalCer) stimulation induced IL-17A production by WT splenocytes but not Rag2 Ϫ / Ϫ splenocytes (Fig. S1, B and C) . Collectively, these data suggest that although T and NKT cells are both major producers of IL-17, populations of non -T, non -B cells can also produce IL-17.
To identify which population of cells might be responsible for IL-23 -dependent IL-17 production by Rag2 Ϫ / Ϫ splenocytes, we examined another genetic model, namely Rag2 Ϫ / Ϫ ␥ c Ϫ / Ϫ mice. In addition to lacking T and B cells, Rag2 Ϫ / Ϫ ␥ c Ϫ / Ϫ mice also lack NK cells. We therefore cultured WT, Rag2 Ϫ / Ϫ , or Rag2 Ϫ / Ϫ ␥ c Ϫ / Ϫ splenocytes in the presence of IL-23. Consistent with Fig. 1 A , IL-17A production was present in WT splenocytes and reduced but not absent in Rag2 Ϫ / Ϫ splenocytes ( Fig. 1 B ) . In contrast, IL-17A production by Rag2 Ϫ / Ϫ ␥ c Ϫ / Ϫ splenocytes was essentially abrogated ( Fig. 1 B ) . These results indicate that ␥ c-dependent, non -T, non -B cell populations in the spleen can produce IL-17 in vitro.
IL-23 has been shown to be induced by certain microbial products ( 15 ) . Rag2 Ϫ / Ϫ mice were therefore injected with zymosan to induce IL-23 production by DCs, which resulted in rapid IL-17A appearance in sera and spleens ( Fig. 1 C ) . Thus, these data indicate that innate immune cells can generate IL-17 in response to the fungal product in vivo.
IL-17 production by CD4 + CD3 ؊ CD11c ؊ B220 ؊ LTi-like cells To delineate the population of IL-17 -producing cells, we next used intracellular cytokine staining. We used markers for a variety of innate immune cells expected to be present in Rag2 Ϫ / Ϫ spleens but failed to detect IL-23 -mediated IL-17A production in granulocytes, macrophages, or DCs (Fig. S2 , available at http://www.jem.org/cgi/content/full/jem .20072713/DC1). A prominent ␥ c-dependent lineage that rapidly produces cytokines upon stimulation is the NK cell. Based on the response to IL-23 in Rag2 Ϫ / Ϫ splenocytes and loss in Rag2 Ϫ / Ϫ ␥ c Ϫ / Ϫ splenocytes, we thought that NK cells could be IL-17 producers. However, contrary to our expectations, the majority of IL-17A -producing CD3 Ϫ cells did not express NK1.1 ( Fig. 2 A ) . Thus far, our results have indicated that neither T, NKT, NK cells (all ␥ c dependent) nor ␥ c-independent myeloid cells were a major source of IL-17 production in Rag2 Ϫ / Ϫ spleens. We did observe that in Rag2 Ϫ / Ϫ splenocytes stimulated with IL-23 ( Fig. 2 B , left) , a considerable proportion of the IL-17A -producing non -T cells expressed CD4 ( Fig. 2 B , right) .
CD4 + CD3 Ϫ cells in the Rag2 Ϫ / Ϫ spleen comprise three populations, including CD11C low B220 + plasmacytoid DCs, CD11C + B220 Ϫ conventional DCs, and CD4 + CD3 Ϫ CD11c Ϫ B220 Ϫ cells (Fig. S3 , available at http://www.jem.org/cgi/ content/full/jem.20072713/DC1). As indicated in Fig. S2 , the yeast wall product zymosan elicited IL-17 production by LTi-like cells in vivo. Whether the production of IL-17 and IL-22 infl uences the architecture of secondary lymphoid organs (SLOs) and contributes to host defense will be important issues to examine in the future.
RESULTS AND DISCUSSION
IL-23 induces IL-17 production by a population of common ␥ chain ( ␥ c) -dependent non -T, non -B cells To determine if there are considerable proportions of innate immune cells that produce IL-17, we examined Rag2 Ϫ / Ϫ mice that have few T and B cells. We fi rst assessed whether IL-17 production occurred in Rag2 Ϫ / Ϫ splenocytes after stimulation with various cytokines. As shown in Fig. 1 A , IL-23 alone induced IL-17A production by WT splenocytes, presumably indicative of an eff ect on memory T cells. Consistent with the idea that memory T cells are lacking in Rag2 Ϫ / Ϫ mice, the eff ect of IL-23 was reduced in Rag2 Ϫ / Ϫ splenocytes ( Fig. 1 A ) . However, Rag2 Ϫ / Ϫ splenocytes still produced about one third as much IL-17A as WT splenocytes ( Fig. 1 A ) . Other cytokines used separately or in combination 
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to maintain cells for the initial 48 h, followed by IL-23 for another 6 h. As shown in Fig. S7 A, IL-17A and IL-17F mRNA expression was potently induced by IL-23 in the presence of IL-7. These results suggest that LTi-like cells quickly enhance the production of IL-17 in response to IL-23, and this cytokine does not simply serve to keep these cells alive.
It is well known that Stat3 is activated by IL-23 and other inducers of Th17 cell diff erentiation, and the absence of Stat3 abrogates IL-17 production by T cells ( 12 ) . We therefore assessed the proportion of IL-17A -producing LTi-like cells in Stat3-defi cient mice. Not surprisingly, we found that IL-23 -mediated IL-17A production was decreased in Stat3-defi cient LTi-like cells of Stat3 fl /fl ; MMTV-Cre or Stat3 fl /fl ; CD4-Cre splenocytes compared with those of Stat3 fl /fl splenocytes, although IL-17A production was not completely abrogated ( Fig. 3 B and not depicted). Because Cre-mediated deletion of STAT3 is > 90% in both systems (unpublished data), there seems to be both STAT3-dependent and -independent pathways for the production of IL-17 in LTi-like cells. We also observed that IL-23 up-regulated mRNA expression of Stat3 and Stat4 but not GATA3 in LTi-like cells (Fig. S7 B) . These results highlight the notion that the IL-17 production by LTi-like cells might be dependent on these factors.
LTi-like cells constitutively express IL-23R, AHR, and CCR6
The complete receptor for IL-23 comprises the IL-12R ␤ 1 associated with the ligand-specifi c subunit IL-23R, and both subunits are required for the action of this cytokine ( 4 ) . As memory CD4 + T cells respond to IL-23 because of constitutive expression of its receptors ( 4 ), we evaluated mRNA expression of IL-23R and IL-12R ␤ 1 in LTi-like cells. Consistent with their rapid responsiveness to IL-23, LTi-like cells constitutively expressed IL-23R mRNA at levels signifi cantly greater than T cells ( Fig. 3 C ) . LTi-like cells also expressed slightly higher levels of IL-12R ␤ 1 mRNA compared with those of memory CD4 + T cells ( Fig. 3 C ) . In contrast, expression levels of IL-12R ␤ 2 mRNA in LTi-like cells were low compared with those in memory CD4 + T cells ( Fig. 3 C ) . Also consistent with previous studies ( 16, 18 ) , we noted higher expression levels of ROR ␥ t mRNA in LTi-like cells compared with T cells ( Fig. 3 C ) . In contrast, expression of IL-6R ␣ and IL-17RA mRNA in LTi-like cells was much lower compared with that in T and B cells (unpublished data). Recently, the AHR has been reported to be expressed in Th17 cells ( 14 ) . Interestingly, LTi-like cells also expressed AHR mRNA at levels equivalent to those in Th17 cells polarized for 72 h ( Fig. 3 C ) . Furthermore, IL-23 up-regulated mRNA expression levels of IL-23R, ROR ␥ t, and AHR (Fig. S7 C) .
Consistent with previous studies ( 16, 18 ) , splenic LTi-like cells were found to be CD30L + OX40L + ␥ c + IL-7R ␣ + Thy1.2 high CD44 high CD62L low (Fig. S6) . LTi-like cells are also known to express the chemokine receptors CXCR5 + and CCR7 + ( 16, 18 ) , and we again confi rmed expression of these in the splenic LTi-like cells (Fig. S6) . Additionally, it has recently been shown that CCR6 identifi es a population of human we did not detect IL-23 -mediated IL-17A production by CD11C + DC populations. The latter, CD4 + CD3 Ϫ CD11c Ϫ B220 Ϫ cells, have been shown to be present in SLOs of fetal and adult mice and are termed LTi ' s and LTi-like cells, respectively ( 16 ) . Importantly, LTi-like cells are greatly reduced in ␥ c Ϫ / Ϫ mice ( 17 ) .
We next determined whether isolated CD4 + CD3 Ϫ CD11c Ϫ B220 Ϫ LTi-like subsets produced IL-17 ( Fig. 3 A ,  top) . In fact, as shown in Fig. 3 A (bottom) , we observed IL-17A production by isolated LTi-like cells in response to IL-23. Moreover, directly isolated LTi-like cells produced more IL-17A in the presence of PMA/ionomycin (Iono), which was dramatically enhanced by IL-23 ( Fig. 3 A , bottom) . In contrast, LTi-negative subsets produced minimal IL-17A (Fig. S4, available (Fig. S5) . These results suggest that the ability to produce IL-17 is not unique to the splenic population.
One possible explanation for our observations is that IL-23 promoted in vitro survival of LTi-like cells rather than enhancing IL-17 production by itself. LTi-like cells have been shown to express IL-7Rs (Fig. S6 , available at http://www .jem.org/cgi/content/full/jem.20072713/DC1) ( 16 ) . Therefore, we modifi ed the cell-culture conditions by adding IL-7 tion of IL-17A -producing LTi-like cells was determined by FACS. As shown in Fig. 4 (top) the proportion of IL-17 -producing LTi-like cells was signifi cantly greater in zymosan-treated mice compared with control mice. To further establish the ability of LTi-like cells to produce IL-17 in vivo, we treated Rag2 Ϫ / Ϫ mice with BFA i.v. ( 21 ) and challenged them with zymosan i.p. for 6 h. We observed few IL-17A -producing LTi-like cells in control mice, whereas zymosan-treated mice had a signifi cant increase in IL-17A -producing cells ( Fig. 4 , bottom) . These results establish that LTi-like cells can rapidly produce IL-17 in vivo when challenged with the product of fungal pathogens.
LTi-like cells also produce IL-22
It has been argued that Th17 cells also preferentially produce IL-22 ( 22 ) . Interestingly, we found that treatment with zymosan induced not only IL-17A but also IL-22 in the sera and spleens of Rag2 Ϫ / Ϫ mice ( Fig. 5 A ) . In vitro stimulation with memory CD4 + T cells that selectively produce IL-17 ( 19 ), we found that most of the splenic LTi-like cells express CCR6 ( Fig. 3 D ) . Approximately half of the CCR6 + LTi-like cells coexpressed CXCR5 and CCR7 (unpublished data), suggesting that the expression of those chemokine receptors on LTilike cells is heterogeneous, as previously reported ( 20 ) . On the other hand, the expression of CXCR3, CCR5, or CCR4, which are preferentially expressed on Th1 or Th2 cells ( 19 ) , was low on splenic LTi-like cells (Fig. S6 and not depicted) .
LTi-like cells produce IL-17 during zymosan-induced infl ammation in Rag2 ؊ / ؊ mice
We next determined whether LTi -like cells produced IL -17 in vivo in an infl ammatory setting. We approached this problem in two ways: fi rst, we injected Rag2 Ϫ / Ϫ mice with zymosan i.p. to induce infl ammation and harvested splenocytes 2 h later. The cells were then stimulated ex vivo with PMA/Iono and Brefeldin A (BFA) for 2 h, and the propor- 
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it is becoming increasingly clear that they are not the only source of IL-17. Clearly, ␥ ␦ T and iNKT cells produce IL-17 to protect against bacterial infection ( 6, 7 ) . In addition, a recent study provides evidence that IL-23 can drive IL-17 production by innate immune cells in animal models of infl ammatory bowel disease ( 23 ) .
We were very impressed by the loss of IL-17 production in Rag2 Ϫ / Ϫ ␥ c Ϫ / Ϫ mice ( Fig. 1 B ) . We initially suspected that this pointed to production of IL-17 by NK cells but were surprised by the failure to see IL-17 production by NK1.1 + CD3 Ϫ NK cells ( Fig. 2 A ) . However, LTi-like cells are also dependent on ␥ c cytokines for development ( 17 ) . Before our studies, it was known that these cells expressed ROR ␥ t, which was required for their function in LNs ( 16, 18 ) . ROR ␥ t has several important functions, but it is now clear that one function is the regulation of Th17 cell diff erentiation ( 13 ) . We confi rmed that splenic LTi-like cells constitutively express ROR ␥ t ( Fig. 3 C ) and that IL-23 further up-regulated its expression (Fig. S7 C) , arguing that this factor is essential in controlling IL-17 and IL-22 production by non -T cells. Interestingly, fresh LTi-like cells also constitutively expressed more AHR than polarized Th17 cells ( Fig. 3 C ) . LTi-like cells also constitutively expressed IL-23R and CCR6 ( Fig. 3,  C and D ) , similar to CCR6 + IL-23R + human memory CD4 + T cells, which are major producers of IL-17 ( 19, 24 ) . Thus, the expression of ROR ␥ t, AHR, CCR6, and IL-23R seems to be the signature to defi ne IL-17 -and IL-22 -producing cells in both adaptive and innate immune cells.
LTi-like cells are involved in the proper formation of peripheral LNs, the spleen, and gut-associated lymphoid tissue by highly expressing lymphotoxin ␣ , lymphotoxin ␤ , and TNF-␣ ( 16, 25 ) . Our data indicate that splenic and gut LTilike cells also produce IL-17 and IL-22 ( Figs. 3 A and 5 B ; and Fig. S7, A and D) ( 26 ) . It has been recently shown that blocking IL-17 results in disruption of the germinal centerlike formation in the spleen, and restoration of the lymphoid microanatomy is dependent on the proliferative accumulation of LTi-like cells in SLOs during viral infection ( 27, 28 ) . In addition, the cross talk between bacteria, LTi cells, stromal cells, DCs, and B cells seems to be essential for isolated lymphoid follicle formation in the gut ( 29 ) . LTi-like cells might IL-23 induced more IL-22 production by Rag2 Ϫ / Ϫ splenocytes than WT splenocytes ( Fig. 5 B ) . Furthermore, isolated LTi-like cells also produced IL-22 ( Fig. 5 B and Fig. S7 D) . Although we observed that NK1.1 + CD3 Ϫ NK cells failed to produce IL-17A ( Fig. 2 A ) , isolated NK cells produced small amounts of IL-22 in response to IL-23 (Fig. S8 , available at http://www.jem.org/cgi/content/full/jem.20072713/DC1). These fi ndings illustrate the potentially distinct modes of regulation for IL-17 and IL-22.
The IL-23 -IL-17 axis has emerged to be important in host defense and in models of autoimmunity such as experimental autoimmune encephalomyelitis and infl ammatory bowel disease ( 10, 23 ) . Despite the importance of Th17 cells, Data analysis. Statistical signifi cance was determined by the Student ' s t test. P < 0.05 was considered to indicate a signifi cant diff erence.
Online supplemental material. Fig. S1 shows IL-17A production by WT or Rag2 Ϫ / Ϫ splenocytes in the presence of IL-23 with ␥ c-dependent cytokines, anti-CD3/-CD28, or ␣ -GalCer. Fig. S2 shows that IL-17A -producing CD3 Ϫ cells do not express myeloid markers. Fig. S3 shows three populations in CD4 + CD3 Ϫ cells from Rag2 Ϫ / Ϫ spleens. Fig. S4 shows that LTi-negative subsets produce minimal IL-17A. Fig. S5 shows IL-17A production by LTilike cells in the gut. Fig. S6 shows the surface expression of various markers on LTi-like cells. help organize the development of lymphoid tissues through the production of IL-17. In addition, IL-17 and IL-22 act on epidermal cells, producing antimicrobial products that protect the host from extracellular bacteria and fungi ( 22 ) . Our in vivo experiments in which Rag2 Ϫ / Ϫ mice challenged with zymosan produced IL-17 ( Fig. 4 ) are consistent with the notion that splenic LTi-like cells might participate in host defense. It is therefore possible that splenic LTi-like cells exist not only for the development of SLOs but also for the rapid response to pathogens that elicit IL-17 and IL-22. Thus, our report brings to light new potential roles of LTi-like cells in host defense in addition to their known roles in regulating lymphoid architecture. Isolation of cells and cell culture. Single-cell suspensions were prepared from spleens of healthy 8 -10-wk-old mice. All cell cultures were performed in RPMI 1640 supplemented with 10% FBS, 2 mM l -glutamine, 5 mM Hepes, 100 U/ml Pen-Strep, and 2.5 μ M 2-ME at 37 ° C for 4, 24, or 48 h. Cells stained with the appropriate antibodies were isolated by fl ow cytometric cell sorting using a Mo-Flo cell sorter (Dako). Whole splenocytes or isolated cells were cultured in the presence of 20 ng/ml IL-23, 20 ng/ml IL-4, 10 ng/ml IL-6, 20 ng/ml IL-7, 20 ng/ml IL-15, 20 ng/ml IL-2, 20 ng/ml IL-12, 100 ng/ml IL-21, or 5 ng/ml TGF ␤ -1.
MATERIALS AND METHODS

Recombinant
Flow cytometric analysis and intracellular cytokine staining. Cells were stimulated for 2 h with 50 ng/ml PMA and 1 μ g/ml Iono, followed by incubation with BFA (GolgiPlug; BD) for an additional 2 h. Cells were fi xed in 4% formyl saline and permeabilized with 0.1% saponin permeabilization buff er after surface staining. PE-conjugated anti -IL-17 antibody was used to detect intracellular cytokine levels (BD). Stained cells with the appropriate antibodies were analyzed on a fl ow cytometer (FACSCalibur; BD). Events were collected and analyzed with FlowJo software (Tree Star, Inc.). To evaluate production of IL-17A in vivo, Rag2 Ϫ / Ϫ mice were injected i.p. with 5 or 12.5 mg zymosan (Sigma-Aldrich). Control animals received PBS. To assess in vivo intracellular cytokine levels, 0.25 mg BFA (Sigma-Aldrich) was simultaneously injected i.v., as previously described ( 21 ) .
RNA isolation and measurement of cytokines. Total RNA was isolated using TRI zol reagent (Invitrogen) from freshly isolated
